ICL Historical Income Statement

ICL Stock

USD 4.63 0.07 1.54%

Historical analysis of ICL Israel income statement accounts such as Selling General Administrative of 379.1 M or Total Revenue of 5.7 B can show how well ICL Israel Chemicals performed in making a profits. Evaluating ICL Israel income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of ICL Israel's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining ICL Israel Chemicals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ICL Israel Chemicals is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

About ICL Income Statement Analysis

ICL Israel Chemicals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to ICL Israel shareholders. The income statement also shows ICL investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

ICL Israel Income Statement Chart

ICL Israel Chemicals Income Statement is one of the three primary financial statements used for reporting ICL's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of ICL Israel Chemicals revenue and expense. ICL Israel Income Statement primarily focuses on the company's revenues and expenses during a particular period.

At this time, ICL Israel's Net Income is quite stable compared to the past year. Net Income Applicable To Common Shares is expected to rise to about 2.6 B this year, although the value of Depreciation And Amortization will most likely fall to about 371.6 M.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Minority Interest Net Income From Continuing Ops

Total Revenue

Total revenue comprises all receipts ICL Israel Chemicals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of ICL Israel Chemicals minus its cost of goods sold. It is profit before ICL Israel operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of ICL Israel Chemicals. It is also known as ICL Israel overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of ICL Israel Chemicals whose combined shares represent less than 50% of the total outstanding shares issued by ICL Israel have a minority interest in ICL Israel.

Most accounts from ICL Israel's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into ICL Israel Chemicals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

	2021	2022	2023	2024 (projected)
Interest Expense	216M	327M	176.7M	120.4M
Depreciation And Amortization	588M	713M	590.1M	371.6M

Interest Expense Depreciation And Amortization

ICL Israel income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Minority Interest	Net Income From Continuing Ops	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.81	-0.42	0.64	0.5	0.7	0.39	0.41	0.11	0.53	0.71	0.45	0.36	-0.44	0.23	0.55	0.78	-0.03	0.29	0.58	0.42	0.48	0.71
Interest Expense	0.81		-0.52	0.44	0.41	0.47	0.28	0.31	0.04	0.4	0.42	0.45	0.25	-0.42	0.12	0.48	0.74	-0.16	0.25	0.55	0.43	0.36	0.57
Selling General Administrative	-0.42	-0.52		0.1	0.14	0.06	0.12	0.11	0.45	0.04	0.03	0.09	0.15	0.34	0.21	0.02	-0.79	-0.31	0.1	-0.1	-0.21	-0.28	-0.29
Total Revenue	0.64	0.44	0.1		0.95	0.9	0.85	0.87	0.59	0.9	0.93	0.55	0.84	-0.09	0.77	0.84	0.5	-0.45	0.59	0.72	0.47	0.45	0.43
Gross Profit	0.5	0.41	0.14	0.95		0.74	0.94	0.95	0.48	0.96	0.76	0.47	0.94	-0.08	0.88	0.94	0.42	-0.55	0.73	0.82	0.59	0.47	0.36
Other Operating Expenses	0.7	0.47	0.06	0.9	0.74		0.54	0.57	0.7	0.63	0.97	0.76	0.52	-0.1	0.44	0.59	0.51	-0.34	0.22	0.48	0.2	0.22	0.45
Operating Income	0.39	0.28	0.12	0.85	0.94	0.54		1.0	0.3	0.99	0.63	0.15	1.0	-0.06	0.98	0.91	0.36	-0.47	0.88	0.81	0.67	0.62	0.29
Ebit	0.41	0.31	0.11	0.87	0.95	0.57	1.0		0.34	0.99	0.65	0.17	1.0	-0.05	0.97	0.91	0.37	-0.47	0.86	0.8	0.66	0.61	0.29
Research Development	0.11	0.04	0.45	0.59	0.48	0.7	0.3	0.34		0.33	0.64	0.62	0.32	0.39	0.31	0.27	-0.03	-0.26	0.01	0.09	-0.04	-0.12	-0.13
Ebitda	0.53	0.4	0.04	0.9	0.96	0.63	0.99	0.99	0.33		0.71	0.22	0.98	-0.11	0.94	0.93	0.46	-0.44	0.84	0.83	0.68	0.64	0.37
Cost Of Revenue	0.71	0.42	0.03	0.93	0.76	0.97	0.63	0.65	0.64	0.71		0.57	0.61	-0.1	0.55	0.61	0.54	-0.28	0.34	0.5	0.27	0.37	0.46
Total Operating Expenses	0.45	0.45	0.09	0.55	0.47	0.76	0.15	0.17	0.62	0.22	0.57		0.15	-0.06	0.02	0.37	0.28	-0.36	-0.14	0.28	-0.02	-0.24	0.28
Income Before Tax	0.36	0.25	0.15	0.84	0.94	0.52	1.0	1.0	0.32	0.98	0.61	0.15		-0.03	0.98	0.91	0.32	-0.48	0.87	0.8	0.67	0.6	0.26
Total Other Income Expense Net	-0.44	-0.42	0.34	-0.09	-0.08	-0.1	-0.06	-0.05	0.39	-0.11	-0.1	-0.06	-0.03		0.04	-0.13	-0.41	0.24	-0.19	-0.33	0.14	-0.15	-0.9
Net Income	0.23	0.12	0.21	0.77	0.88	0.44	0.98	0.97	0.31	0.94	0.55	0.02	0.98	0.04		0.81	0.22	-0.43	0.84	0.68	0.61	0.59	0.16
Income Tax Expense	0.55	0.48	0.02	0.84	0.94	0.59	0.91	0.91	0.27	0.93	0.61	0.37	0.91	-0.13	0.81		0.45	-0.51	0.82	0.95	0.72	0.52	0.38
Selling And Marketing Expenses	0.78	0.74	-0.79	0.5	0.42	0.51	0.36	0.37	-0.03	0.46	0.54	0.28	0.32	-0.41	0.22	0.45		-0.08	0.26	0.5	0.42	0.54	0.58
Minority Interest	-0.03	-0.16	-0.31	-0.45	-0.55	-0.34	-0.47	-0.47	-0.26	-0.44	-0.28	-0.36	-0.48	0.24	-0.43	-0.51	-0.08		-0.53	-0.54	-0.06	-0.17	-0.33
Net Income From Continuing Ops	0.29	0.25	0.1	0.59	0.73	0.22	0.88	0.86	0.01	0.84	0.34	-0.14	0.87	-0.19	0.84	0.82	0.26	-0.53		0.84	0.68	0.73	0.31
Tax Provision	0.58	0.55	-0.1	0.72	0.82	0.48	0.81	0.8	0.09	0.83	0.5	0.28	0.8	-0.33	0.68	0.95	0.5	-0.54	0.84		0.68	0.55	0.51
Interest Income	0.42	0.43	-0.21	0.47	0.59	0.2	0.67	0.66	-0.04	0.68	0.27	-0.02	0.67	0.14	0.61	0.72	0.42	-0.06	0.68	0.68		0.77	0.03
Net Interest Income	0.48	0.36	-0.28	0.45	0.47	0.22	0.62	0.61	-0.12	0.64	0.37	-0.24	0.6	-0.15	0.59	0.52	0.54	-0.17	0.73	0.55	0.77		0.31
Reconciled Depreciation	0.71	0.57	-0.29	0.43	0.36	0.45	0.29	0.29	-0.13	0.37	0.46	0.28	0.26	-0.9	0.16	0.38	0.58	-0.33	0.31	0.51	0.03	0.31

Click cells to compare fundamentals

ICL Israel Account Relationship Matchups

ICL Israel income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	535M	555M	588M	713M	590.1M	371.6M
Interest Expense	220M	219M	216M	327M	176.7M	120.4M
Selling General Administrative	254M	232M	276M	291M	436M	379.1M
Total Revenue	5.3B	5.0B	7.0B	10.0B	7.7B	5.7B
Gross Profit	1.8B	1.5B	2.6B	5.0B	2.6B	2.2B
Other Operating Expenses	4.5B	4.8B	5.7B	6.5B	6.4B	4.6B
Operating Income	756M	202M	1.2B	3.5B	1.2B	1.1B
Ebit	756M	202M	1.2B	3.5B	1.2B	1.1B
Research Development	50M	54M	64M	68M	72.1M	61.5M
Ebitda	1.3B	757M	1.8B	4.2B	1.8B	1.4B
Cost Of Revenue	3.5B	3.6B	4.3B	5.0B	5.1B	3.5B
Total Operating Expenses	1.1B	1.3B	1.4B	1.5B	1.4B	1.1B
Income Before Tax	628M	49M	1.1B	3.4B	988.3M	968.8M
Total Other Income Expense Net	(128M)	(153M)	(118M)	(112M)	(232.6M)	(221.0M)
Net Income	475M	24M	783M	2.2B	647M	751.3M
Income Tax Expense	147M	25M	260M	1.2B	291.5M	217.3M
Selling And Marketing Expenses	767M	766M	1.1B	1.2B	917M	702.3M
Net Income Applicable To Common Shares	475M	11M	783M	2.2B	2.5B	2.6B
Minority Interest	136M	158M	(49M)	(60M)	(34M)	(32.3M)
Net Income From Continuing Ops	481M	24M	832M	2.2B	945M	770.3M
Tax Provision	147M	25M	260M	1.2B	412M	309.6M
Interest Income	89M	61M	94M	214M	39M	37.1M
Net Interest Income	(106M)	(140M)	(158M)	(122M)	(113M)	(147M)
Reconciled Depreciation	443M	489M	490M	498M	526M	509.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:

How To Invest In ICL

Details

Is ICL Stock a good investment?

Details

What is ICL Israel's Net Worth?

Details

Largest Fertilizers & Agricultural Chemicals Companies

View

Largest Agricultural Inputs Companies

View

Note that the ICL Israel Chemicals information on this page should be used as a complementary analysis to other ICL Israel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for ICL Stock analysis

When running ICL Israel's price analysis, check to measure ICL Israel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICL Israel is operating at the current time. Most of ICL Israel's value examination focuses on studying past and present price action to predict the probability of ICL Israel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICL Israel's price. Additionally, you may evaluate how the addition of ICL Israel to your portfolios can decrease your overall portfolio volatility.

	Money Managers Screen money managers from public funds and ETFs managed around the world
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules

Is ICL Israel's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.80)

Dividend Share

0.277

Earnings Share

0.5

Revenue Per Share

5.845

Quarterly Revenue Growth

(0.19)

The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ICL Historical Income Statement

About ICL Income Statement Analysis

ICL Israel Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Minority Interest

ICL Israel income statement Correlations

ICL Israel Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ICL Israel income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for ICL Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebit	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Ebit
Ebitda	+ 0.99	Operating Income
Ebitda	+ 0.99	Ebit
Net Income	+ 0.98	Operating Income

Reconciled Depreciation	- 0.9	Total Other Income Expense Net
Selling And Marketing Expenses	- 0.79	Selling General Administrative
Minority Interest	- 0.55	Gross Profit
Tax Provision	- 0.54	Minority Interest
Net Income From Continuing Ops	- 0.53	Minority Interest
Selling General Administrative	- 0.52	Interest Expense